XLON
KRM
Market cap27mUSD
Oct 06, Last price
34.50GBP
1D
0.00%
1Q
-21.59%
IPO
-75.87%
Name
KRM22 PLC
Chart & performance
P/E
—
P/S
2.75
EPS
—
Div yield, %
—
Shrs. gr., 5y
3.54%
Rev. gr., 5y
10.12%
Revenues
7m
+9.90%
Net income
-2m
L+56.57%
CFO
2m
+67.11%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
KRM22 Plc, together with its subsidiaries, develops and sells risk management software to the financial services industry in the United Kingdom, Europe, the United States, and internationally. The company offers Risk Cockpit, a digital risk register and incident management portal that brings risk policies and operational controls to life through a proven risk assessment workflow; and Market Surveillance that offers analytics and contextual market surveillance to help capital market firms to identify and manage the potential risks of market abuse and operational breaches. It also provides Limits Manager that combats time consuming and error prone processes by maintaining, auditing, and approving trading limits across multiple platforms in one centralised application; and Risk Manager which integrates the functionality from the At-Trade P&L and Post-Trade stress applications helping firms achieve risk management monitoring. The company was founded in 2017 and is headquartered in London, the United Kingdom.
Related entities
Subsidiaries
KRM22 CENTRAL LTD
Key people
Garry Jones
Non-Executive Chairman of the Board · since 2024
Kim Suter
Chief Financial Officer, Company Secretary, Director · since 2024
Dan Carter
Chief Executive Officer, Executive Director · since 2024
Keith Todd
Executive Director · since 2024
Sandy Broderick
Non-Executive Director · since 2024
Justin Llewellyn-Jones
Non-Executive Director · since 2026
Headquarters & legal address
8th Floor Capital House, 84 - 86 King William Street,
LONDON EC4N 7BL
GB
LONDON EC4N 7BL
GB
Valuation
Title GBP in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||